Profile data is unavailable for this security.
About the company
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
- Revenue in EUR (TTM)22.23m
- Net income in EUR-22.98m
- Incorporated2002
- Employees242.00
- LocationMedian Technologies SALes Deux Arcs - Batiment B 1800Route des CretesVALBONNE 06560FranceFRA
- Phone+33 493333777
- Fax+33 492906599
- Websitehttps://mediantechnologies.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Global Bioenergies SA | 3.25m | -8.66m | 28.66m | 46.00 | -- | 2.75 | -- | 8.82 | -0.4797 | -0.4797 | 0.1802 | 0.5743 | 0.1632 | 5.21 | 65.62 | 70,638.05 | -43.47 | -43.66 | -64.54 | -82.47 | -153.20 | -948.35 | -266.41 | -1,331.36 | 3.54 | -- | 0.2626 | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
Biosynex SA | 92.98m | -37.12m | 30.18m | 575.00 | -- | 0.2463 | -- | 0.3246 | -3.64 | -3.64 | 9.10 | 11.92 | 0.3704 | 1.16 | 7.34 | 161,700.90 | -14.18 | 14.90 | -17.51 | 19.41 | 52.84 | 51.92 | -38.30 | 14.61 | 1.03 | -28.00 | 0.3459 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
AbL Diagnostics SA | 11.19m | 1.20m | 46.73m | 19.00 | 73.90 | 6.96 | 154.02 | 4.18 | 0.0392 | 0.0392 | 0.483 | 0.4165 | 1.18 | -- | 5.21 | 588,990.50 | 12.67 | 8.99 | 26.09 | 10.77 | 35.76 | 38.29 | 10.75 | 31.17 | 1.28 | -- | 0.31 | 0.00 | -- | 67.89 | 328.77 | -- | 43.20 | -- |
Median Technologies SA | 22.23m | -22.98m | 48.19m | 242.00 | -- | -- | -- | 2.17 | -1.26 | -1.26 | 1.21 | -0.5608 | 0.6289 | -19.61 | 3.55 | 91,842.98 | -65.02 | -54.57 | -186.81 | -157.51 | 104.50 | 101.57 | -103.40 | -93.70 | 1.40 | -- | 2.21 | -- | -6.10 | 28.52 | -13.70 | -- | 38.38 | -- |
Affluent Medical SAS | 0.00 | -15.65m | 51.04m | 59.00 | -- | 1.51 | -- | -- | -0.5409 | -0.5409 | 0.00 | 1.02 | 0.00 | -- | -- | 0.00 | -26.83 | -- | -31.42 | -- | -- | -- | -- | -- | -- | -24.43 | 0.328 | -- | -- | -- | -2.80 | -- | -- | -- |
Visiomed Group SA | 13.71m | 902.00k | 52.89m | 94.00 | 0.1074 | 2.10 | 9.55 | 3.86 | 1.60 | 1.60 | 0.0383 | 0.0819 | 0.3772 | 2.40 | 9.07 | 145,808.50 | 2.48 | -29.88 | 2.84 | -57.19 | 94.24 | 51.88 | 6.57 | -59.42 | 1.71 | 0.2127 | 0.2426 | -- | -5.12 | 9.42 | 117.09 | -- | 27.51 | -- |
Holder | Shares | % Held |
---|---|---|
Herald Investment Management Ltd.as of 31 Dec 2023 | 522.35k | 2.84% |
Aguja Capital GmbHas of 30 Jun 2023 | 512.69k | 2.79% |
Apo Asset Management GmbHas of 30 Apr 2024 | 477.24k | 2.59% |
Financi�re Arbevel SAas of 30 Dec 2022 | 412.66k | 2.24% |
Discover Capital GmbHas of 31 Dec 2023 | 200.00k | 1.09% |
Mandarine Gestion SAas of 29 Feb 2024 | 115.00k | 0.63% |
Lonvia Capital SASUas of 30 Jun 2023 | 96.18k | 0.52% |
Cholet Dupont Asset Management SAas of 30 Jun 2023 | 76.23k | 0.41% |
Pure Capital SAas of 31 Dec 2023 | 68.29k | 0.37% |
G�n�rali Investments Partners SpA SGR (France)as of 28 Feb 2022 | 65.00k | 0.35% |